For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments.  Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others.

Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has five manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in New Drug Development, etc.

Post : Trainee Chemist

Evertogen’s journey began with a single client in July 2013; today we are proud partners of nearly twenty clients spread across the globe (Europe, USA, Canada, South Africa, Australia, Ukraine & others). Our growth stems from our dynamism and the promise of quality, accuracy, transparency & speed, with which we relentlessly deliver to all our clients. With a flat organization structure in place, about 250 employees has the freedom to communicate and function in a fair & collaborative environment.

Maithri Drugs is one of Indias fast-growing pharmaceutical companies. Maithris strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its excellent research and development and aggressive growth strategies. Our 39 US DMFs and 14 CEPs in a short span attest to our R&D excellence.

Human Resources Department walk-in drive.

This marketing authorisation granted to Venus Pharma GmbH, the German subsidiary of Venus Remedies, by one of the world’s most stringent healthcare regulatory agencies will enable the company to offer its affordable range of cancer drugs to the National Health Service (NHS) in the UK and neighbouring countries.

Ipca Laboratories to acquire 33.38 percent shares in Unichem Laboratories for Rs 1034.06 Crores. Ipca Laboratories announced that the company has entered into a definitive Share Purchase Agreement (SPA) for acquisition of 2,35,01,440 fully paid-up equity shares of Rs. 21- each, constituting 33.38% of the paid up equity share capital of Unichem Laboratories Ltd. (Unichem), from one of its promoter shareholder at a price at Rs. 440 per equity share aggregating to Rs; 1034.06 Crores.

A new flexible bio-electronic uric acid detecting device has been fabricated that can be used for various applications such as wearable sensors and point-of-care diagnostics.

The Union Cabinet, chaired by the Hon'ble Prime Minister Shri Narendra Modi, today approved the National Medical Devices Policy, 2023.

The AIIMS, New Delhi model will be adopted and adapted. Unlike the Postgraduate Institutes which lack the basic departments like Anatomy, Physiology, Pharmacology, General Medicine, Surgery, Obstetrics & Gynaecology etc, the new AIIMS will have these departments as well as the superspecialty departments like neurosurgery, cardiac surgery, urology, endocrinology etc.

National Institute of Pharmaceutical Education and Research, Kolkata (NIPER-K) was created in 2007 under the aegis of Ministry of Chemicals & Fertilizer as a centre of excellence for higher education, research and development in Pharmaceutical Sciences. This followed the establishment of NIPER Mohali, which is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences.

Balasore is one of the coastal Districts of Odisha. It lies on the northern most part of the state. It was a part of the ancient Kalinga which later became a territory of Toshal or Utkal, till the death of Mukunda Dev. Balasore as a separate District was created in October 1828. originally it was in Bengal presidency.  Balasore District covers an area of 3634 sq kms having total population of 23,17,419 as per 2011 census.

Post :

Founded in 2002, we are a clinical stage biotech company committed to the discovery and development of novel and effective therapeutics for the treatment of cancer.  We leverage our deep expertise in oncology focused novel therapeutics for the benefit of cancer patients everywhere.

Post : Sr. Scientist - DMPK (in vitro ADME & Bioanalysis)

The AIIMS, New Delhi model will be adopted and adapted. Unlike the Postgraduate Institutes which lack the basic departments like Anatomy, Physiology, Pharmacology, General Medicine, Surgery, Obstetrics & Gynaecology etc, the new AIIMS will have these departments as well as the superspecialty departments like neurosurgery, cardiac surgery, urology, endocrinology etc.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Founded in 1946, we work with a unique business model across the Agchem value chain from R&D to distribution providing innovative solutions by partnering with the best. Known for our technological capabilities in Chemistry/ Engineering related services and on the other hand, have built leading brands over the last 75 years and connected with more than 70,000 retail points pan India.

Post : Research Scientist (Process R&D)

Founded in 2002, we are a clinical stage biotech company committed to the discovery and development of novel and effective therapeutics for the treatment of cancer.  We leverage our deep expertise in oncology focused novel therapeutics for the benefit of cancer patients everywhere.

Post : Scientist - Cell & Molecular Biology

Novozymes is the world’s leading provider of industrial enzymes and microorganisms. Together with our customers, partners, and the global community, we use our innovative thinking and passion for science to boost industries and make everyday products more sustainable for the good of the planet. Our biological solutions enable higher agricultural yields, healthy food consumption, low-temperature washing, energy-efficient production, renewable fuel, and many other biological solutions that the world can benefit from – both today and in years to come.

Syngene International Ltd is an integrated research, development and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors. Syngene’s 4500+ scientists offer both skills and the capacity to deliver great science, robust data management and IP security and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.

Arterial stiffness may be a novel risk factor for metabolic syndrome in teens, a paper published in the American Journal of Physiology-Heart and Circulatory Physiology concludes. The study was conducted in collaboration between the University of Bristol in the UK, the University of Exeter in the UK, and the University of Eastern Finland.